300717.Sz

The company maintains a market price of 19.93 CNY per share, with a market capitalization of 2,048,305,750 CNY. Its price-to-earnings ratio is 37.21, and the price-to-book ratio is 2.81, indicating a relatively high valuation compared to its book value. The enterprise value to EBITDA ratio is 34.61, suggesting a premium valuation relative to its earnings before interest, taxes, depreciation, and amortization.

Profitability metrics show a return on equity of 7.56% and a return on assets of 5.49%, which are below the industry median for Commodity Chemicals. The company's gross profit margin is 31.40% (112,963,980 / 359,745,840), and its operating margin is 17.50% (62,934,440 / 359,745,840), both of which are in line with the industry average. However, the net profit margin of 15.30% (55,040,470 / 359,745,840) is slightly below the median for the sector.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The company's total revenue of 359,745,840 CNY is derived from a single product line, with no significant diversification across product offerings.

The company's growth trajectory is modest, with a free cash flow of 10,125,260 CNY and a capital expenditure of -49,387,300 CNY. The negative capital expenditure indicates a reduction in investment in long-term assets, which may signal a slowdown in expansion or a focus on cost-cutting. The company's operating cash flow of 82,298,040 CNY supports its liquidity position, but the net cash position is negative after subtracting total debt.

The company faces moderate liquidity risk, with a current ratio of 1.83 and a debt-to-equity ratio of 0.18. The risk assessment indicates a medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. The dilution risk is low, with no significant dilution potential in the near term. The company's capital structure is relatively conservative, with a low debt burden and a strong equity base.

Recent events include a 10-K filing that outlines potential risks related to raw material price volatility and regulatory compliance. The company has not issued any new shares in the past 12 months, and there are no indications of a pending equity offering. The company's recent financial performance has been stable, with consistent revenue and profit margins, but there are no significant new product launches or market expansions reported in the latest filings.